Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AbCellera Biologics Inc. (ABCL)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-KS-1
Net income  158.5153.5118.9-2.2 
Depreciation and amortization   [+]27.828.94.81.60.0
Stock-based compensation  49.530.68.40.90.3
Deferred taxes  -2.1-2.02.1 -0.8
Change in working capital   [+]-95.8-35.958.7-0.81.6
Other operating activities  139.469.5-170.23.2 
Cash from operations  277.4244.622.72.7-1.3
   
Capital expenditures  -70.7-58.5-9.7-4.00.0
Purchases of intangible assets  -2.0 -5.0  
Acquisitions   -11.5-87.6  
Purchases of short-term investments, net  -253.4-247.1  -0.2
Other cash from investing  -26.6-15.2-17.5-1.8 
Cash from investing  -352.6-332.2-119.8-5.8-0.2
   
Issuance of common stock, net    522.8  
Option exercises     0.0 
Other cash from financing  -1.6-3.9160.80.2 
Cash from financing  -1.6-3.9683.70.20.0
   
Free cash flow  206.7186.113.0-1.3-1.3
        Per share (diluted)  $0.66$0.58$0.05($0.01) 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy